Breast cancer remains the most prevalent cancer among women globally, with approximately 2.26 million new cases and nearly 685,000 deaths reported in 2020. As the leading cause of cancer-related fatalities in women, early detection, advanced treatments, and comprehensive care are essential in the battle against this disease. The Burjeel Cancer Institute (BCI), which serves over 5,000 oncology patients annually, including those with breast cancer, and conducts more than 10,000 radiotherapy sessions, is at the vanguard of breast cancer care in the UAE. Under the umbrella of Burjeel Holdings, BCI consolidates one of the largest cancer care networks, offering 360-degree care from diagnosis to survivorship programs, reaffirming its position as a leader in comprehensive cancer care in the UAE.
Every October, Breast Cancer Awareness Month serves as a platform to educate the public about the impact of breast cancer on millions of lives. Proper awareness empowers individuals to take control of their health and fosters open discussions about the disease. A key initiative by BCI during this month is the 'Scan for Life' campaign, which underscores the importance of regular breast cancer screenings for early detection. This campaign aims to reach as many women as possible, educating them about the significance of breast cancer awareness and the necessity of regular screenings. Throughout October, BCI will offer mammograms and other preventive screenings through its Pink Truck, a mobile mammography unit that will visit multiple locations across the UAE. This mobile service is complemented by the comprehensive diagnostic services available at Burjeel Holdings' facilities in Abu Dhabi, Al Ain, Sharjah, and Al Dhafra.
BCI is equipped with state-of-the-art technology that enhances precision, efficiency, and comfort in diagnosis and treatment. The institute uses advanced systems such as HOLOGIC's 3Dimensions™ Mammography System, the Elekta Versa HD™ Linear Accelerator for radiotherapy, and the Da Vinci Xi™ robotic surgical system. BCI also houses specialised chemotherapy suites and surgical oncology clinics, supported by a multidisciplinary team of over 50 specialists. The OncoHelix Co-Lab employs cutting-edge technologies like Next-Generation Sequencing (NGS) and Droplet Digital PCR to provide highly accurate diagnostic services.
At the core of BCI's services is its commitment to personalised, patient-centered care. The Advanced Breast Cancer Services Unit offers consultations, diagnostic procedures, and customised treatment plans tailored to each patient's needs. The unit is staffed by female oncologists, surgeons, and radiologists, ensuring a comfortable and private environment for all women. BCI's support extends beyond diagnosis and treatment, offering a survivorship program that provides ongoing support and enhances the quality of life for survivors.
While Breast Cancer Awareness Month in October is a focal point, BCI's commitment to breast cancer awareness and treatment is year-round. The institute hosts community engagement events, educational seminars, and regular screening programs to empower women with knowledge about breast cancer and encourage regular screenings. BCI remains dedicated to being a beacon of hope for cancer patients, offering world-class treatment options and attracting patients from across the region seeking advanced, integrated care.
